Cambridge, United States
Nanopath
$25.0M
Series B
Summary
Nanopath closed a $25 million Series B financing that includes $2 million in grants. Nanopath is a point-of-care molecular diagnostics developer.
Investors
Norwest, SV Health Investors' MedTech Convergence Fund, Labcorp Venture Fund, Elderberry Ventures, GingerBread Capital, Alumni Ventures